286.6K views | +90 today

Le gouvernement "fera sa part" pour soutenir l'industrie pharmaceutique française (secrétaire d'Etat) #hcsmeufr #esante


PARIS (AFP)--Le gouvernement "fera sa part de ce qui est possible" pour soutenir la croissance d
No comment yet.

#HealthTech : Startups en oncologie, rentrez dans l’aventure REALIZE avec AstraZeneca #hcsmeufr #esante


AstraZeneca a lancé REALIZE, son programme d’accompagnement destiné aux startups spécialisées en oncologie. L’appel à projets se termine le 15 février.
No comment yet.

Why Roche's $1.9 Billion Deal to Buy Flatiron Health Matters #hcsmeufr #esante #digitalhealth


Swiss drug giant Roche is set to buy cancer data specialist Flatiron Health for $1.9 billion. Here's why that matter for drug development.
No comment yet.

Roche acquiert Flatiron Health #hcsmeufr #esante #pharma


Le groupe pharmaceutique suisse devra verser 1,9 milliard de dollars à Flatiron.
No comment yet.

5 Ways Digital has Reshaped Pharma Marketing  #hcsmeufr #esanté #digitalhealth


Healthcare sector might be slow to adapt to the digital marketing revolution. But these days pharmaceutical marketing companies are making some big steps towards digitization and are quickly developing a series of innovative digital pharma marketing strategies.

Euris's curator insight, February 13, 5:14 AM
Share your insight

Pharma wades into the world of virtual reality marketing  #hcsmeufr #esanté #digitalhealth


The scene opens with ambulance alarms sounding. Emily, a bicyclist struck by a car, lies on the pavement as a team of EMT workers maneuver her onto a backboard.

Viewers watch it all through the eyes of one of those workers, Han, a migraine sufferer. His vision slowly gets blurrier and the whooping of the sirens turns to a dull ringing noise. The scene fades away as a voiceover intones, "Two in three sufferers downplay the severity of their migraine while at work," guiding viewers to the website for GlaxoSmithKline plc's Excedrin (aspirin/paracetamol/caffeine).

It's one of the latest examples of pharma companies investing in virtual reality (VR) to market their products. Though several years old, the technology is still considered a novel way to educate consumers about a disease or convince physicians to prescribe a certain treatment.

It's early days, with drugmakers still figuring out where VR fits into their larger sales strategies. Digital marketing specialists note the technology is more successful at telling particular stories, depending on factors like therapeutic area.

Defining return on investment can also be tricky given that often the aim of VR campaigns is to elicit empathy — a metric more difficult to measure than revenue or prescription volume. There's also the question of whether VR will be a lasting tool for pharma marketers, or fall to the wayside as newer innovations steal its shine.

At least for now, it looks as though VR has taken root across some of the biggest names in drugmaking. Pfizer Inc. and Novartis AG are deploying the technology in the lab; Amgen Inc. offers a virtual tour of its manufacturing facilities on its website; and Merck KGaA has experimented with its branding applications. Kalorama Information, a research firm focused on healthcare, estimates the virtual reality market for healthcare in the U.S. grew from $525 million in 2012 to nearly $1 billion by spring 2017.

No comment yet.

Inscription Conférence-Débat ACL-CIP du 13 février 2018  PROFESSIONNELS DES PRODUITS DE SANTE - QUEL AVENIR A 10 ANS ? #hcsmeufr #pharma


Les Associations ACL et CIP ont le plaisir de vous inviter à la Conférence-Débat qui aura lieu le jour de leurs assemblées générales le :
Cette conférence, ouverte à tous les responsables des entreprises et décideurs dans le secteur des médicaments et des produits de santé en France, aura pour thème :
Lionel Reichardt / le Pharmageek:
Les Associations ACL et CIP ont le plaisir de vous inviter à la Conférence-Débat qui aura lieu le jour de leurs assemblées générales le : 

    Cette conférence, ouverte à tous les responsables des entreprises et décideurs dans le secteur des médicaments et des produits de santé en France, aura pour thème :



No comment yet.

Worth knowing: 5 Ways to Attract More Patients Online in 2018  #hcsmeufr #esante #digitalhealth


The New Year is a great opportunity to pause and think ‘big picture’ about your medical practice. It’s easy to get caught up in the day-to-day of running the practice – treating patients, managing staff, and putting out fires all day long. BUT what is the point of these daily efforts if ultimately they do not contribute toward a bigger, strategic plan?

At Red Castle Services, it is our firm belief that patient behavior is changing. Every year, more and more patients are searching for their next doctor ONLINE. Gone are the days when patients looked up the doctor’s number in a paper directory. Is this trend likely to stop? In a word, NO. So as a doctor, it’s very important that you are aware of this and start to strategically position your practice accordingly.

The good news is that the solution is really very simple and has just 2 basic components: First, make your practice easy for patients to find online. Second, make sure that what they find persuades them to schedule an appointment. But this is easier said than done. Below we explain some ideas which will help.

5 Ways to Attract More Patients Online in 2018


1. Medical SEO

It’s really very simple – with more and more patients looking for their next doctor online, you need to make your practice easy for patients to find online. One way to do this is medical SEO. In layman’s terms, medical SEO is the process of positioning your website at the top of online search results. It is common knowledge that Google is the most used search engine, so in terms of winning the most new patients, it makes sense to prioritize getting your practice’s website top of Google.

You are now probably wondering “how can I do medical SEO for my practice’s website?” There are several strategies, ranging from increasing backlinks to your site, improving your site’s content, changing backend settings, among others. However, a word of warning – be careful which SEO company you choose to work with, because using the wrong SEO strategies (essentially cheating the system) can lead to your site being blacklisted with Google. At Red Castle Services, we believe in authentic content creation – helping your site to have the best content, so that Google wants it to be at the top of Google. That’s why we have an in-house team of talented medical content writes who create content on the topics patients want to know about.

Read more about medical seo.

2. New Medical Website

So let’s say you successfully get your site to the top of Google. Thousands of patients are now visiting your site every month. BUT wait. Will patients actually like what they find? Your website is patients’ first impression of your practice – does your site really convey the image you want?

Plus does your site have the functionality which converts browsing into appointments? For example, is your site mobile friendly? As far back as 2015, Google reported that more searches take place on smart phones and tablets than on desktops. So if your site is NOT mobile friendly, then you are missing out on over 50% of your potential online patient referrals! Not sure if your site is mobile friendly or not? Here’s a free tool from Google to check.

Interested in giving your website a fresh lick of paint in 2018? See our medical website portfiolio or Contact Us.

3. Online Reputation

Let’s say it again: If patients don’t like what they find, then they won’t schedule an appointment. And this doesn’t just apply to your website. Try Googling the doctors in your practice now. Do you see that Google review which shows up? That’s exactly what patients see too.

Do you have a good rating? Doctors often come to us and ask us how to improve this rating. It can be very frustrating to them. Sometimes the patient was not even their patient and left a scathing review! It’s quite typical for happy patients to not post anything online, while unhappy patients tell the whole world!

The good news is that we have developed a system which collects real, authentic reviews from patients and posts them online, while simultaneously discouraging negative reviews from going online. Take a look at a sample of our work below:

Read more about Online Reputation Management for Doctors.

4. Social Media

I was never a big fan of social media marketing for doctors, because I never saw a big Return On Income. However, that was until I learned how much it helps with SEO. Social media platforms like Twitter, Facebook, and LinkedIn have very high Domain Authorities. This means that they are sites which Google ‘respects’. In other words, links from these sites are quite valuable and help to move your site up the search engine rankings.

An added bonus of social media campaigns is that they can be used to build online followings and to reinforce your practice’s brand. Want to be seen as the leading practice of your specialty in your area? Social media can help.

Read more about social media marketing for doctors.

5. Google Adwords / Facebook Advertising

If you need patients and need them fast, Google Adwords is a great option. It will leapfrog your website straight to the top of Google search engine results in the sponsored section. However, it comes at a cost. Each time someone clicks on those links, you’re charged a fee (often around $2 to $10 per click, depending on how competitive your keywords are).

Facebook advertising is another option, although personally I think it depends on your specialty. For example, if you’re an urgent care center, then I don’t see the value in Facebook advertising. Anyone who is injured will come to you (Google you) and not be inspired by a post on Facebook to suddenly pay you a visit. However, for more chronic conditions, Facebook advertising can be a good option. Let’s imagine someone who has been suffering with arthritis for several months or even years. Seeing a post on Facebook about how arthritis pain can be cured may indeed persuade them to call you. So for specialties like orthopedics and pain management (among others) it can be a good option.

No comment yet.

Discover who are the most engaging Pharma companies on Twitter - #hcsmeufr #esante #digitalhealth


The first edition of our Pharma Social Media Ranking, the Global Twitter Edition ranking measures the performance of the global corporate Twitter accounts of the 22 largest global pharmaceutical companies, measured by revenue. These accounts were identified via the main website of the respective companies.

The overall performance scores, used to position the companies in our ranking, have been calculated using around 5,000 data points which take the following attributes into consideration.


As a snapshot of performance, we looked at all activity during October 2017.

>>>>> Get the full research here <<<<<<<

With engagement such a key performance metric we first created a weighted formula, incorporating likes, retweets and replies, which produced an engagement score for each account. We then normalised this score taking into account the number of followers and the volume of tweets sent during the period. This resulted in a final engagement score which provides a clearer understanding of whose content is working the best.

So, what’s the most engaging content?





Although more followers provides the opportunity for greater organic reach, it appears to become harder to keep this larger community engaged with valuable timely content. Pharma companies that have invested in building the size of their communities now need to develop content marketing strategies to build a sustainable social platform or run the risk of managing zombie communities.

We can see that it’s relatively easy to build a large following on Twitter, however, it can become an ongoing burden to keep these followers engaged and increasingly unclear where the return on investment will come from.

Some pharma companies have started taking a different approach by seeking to become part of the relevant communities which are already active on Twitter and across other social media platforms.

By putting the interests of patients and patient groups at the centre of a social media strategy, the resulting content marketing proposition, will help a pharma company become a valuable contributor to the community.

This approach is certainly more strategic, plays to the social platforms strengths and has the potential to be more beneficial to corporate reputation and brand positioning in the longer term.

>>>>> Get the full research here <<<<<<<

Liked this post? Please share it to help others find it.

We are Owen Health, a healthcare marketing agency like no other. 

You can read more about our thoughts across healthcare communications, multi-channel marketing, brand strategy, CX and digital marketing for pharma here

And finally, if we’ve piqued your interest and you’d like to find out a little more about our healthcare marketing agency, you’ll find our website here

No comment yet.

Mylan : MyHBP®, une application pour les patients souffrant d’Hypertrophie Bénigne de la Prostate #hcsmeufr #esante 


En partenariat avec Ad Scientiam, Mylan présente MyHBP®, une application santé mobile disponible sur iOS et Android qui accompagne les patients souffrant d’hypertrophie bénigne de la prostate.

No comment yet.

Its 2018... Should #Pharma Still be Scared of Digital?  #hcsmeufr #esante #digitalhealth


One of Pharma's biggest fears when it comes to adopting digital and new technology, is fear of regulations and compliance. To see how much of an issue this re…
No comment yet.

#Étude : MedTech, BioTech... Où en est la France ? - Maddyness  #hcsmeufr #esante #digitalhealth


Le dernier rapport de l'association France Biotech témoigne du dynamisme de l'innovation médicale (MedTech, BioTech...) dans l'Hexagone.
No comment yet.

Selon les industriels de la santé, il est difficile d’accéder aux traitements thérapeutiques de pointe en France - Santé


Le Leem, syndicat des industries pharmaceutiques, alerte sur la perte de vitesse de l’industrie pharmaceutique et ses conséquences pour les patients. Ce sont des... - Santé
No comment yet.

Pharma Has Another Reason To Look Out -- Healthcare Systems Now Plan To Make Their Own Drugs #hcsmeufr #esante #digitalhealth


Bypassing drug companies, healthcare systems are now taking drug costs and availability into their own hands by developing a not-for-profit generic drug company.
No comment yet.

Selon les industriels de la santé, il est difficile d’accéder aux traitements thérapeutiques de pointe en France


Le Leem, syndicat des industries pharmaceutiques, alerte sur la perte de vitesse de l’industrie pharmaceutique et ses conséquences pour les patients. Ce sont des... - Santé
No comment yet.

WeHealth by Servier veut créer la médecine de demain


SERVIER - WEHEALTH compte nouer une quinzaine de partenariats par an avec des start-up

IZYCARDIO's curator insight, January 24, 8:15 AM

La mutation de la #BIGPHARMA est en marche! Une preuve de plus du dynamisme de la E-santé. Même si les modèles économiques restent à préciser...

Reste à conquérir la confiance des patients et des professionnels de santé...

Merck to pilot digital behavioural change programme


Merck is set to pilot a digital behavioural change programme that combines remote health coaching, peer support and connected technology in a number of countries outside the US.The German pharmaceutical company will work with Blue Mesa Health to provide the US digital therapeutics firm’s chronic disease prevention programme to diabetes patients.Merck last year received UK approval for its mature oral diabetes drug Glucophage (metformin) to treat non-diabetic hyperglycaemia or pre-diabetes and is looking to add ‘beyond the pill’ services to its product portfolio.
No comment yet.

TriNetX buffs Sanofi's digital trials and other digital health deals  #hcsmeufr #esante #digitalhealth


Sanofi has found yet another partner to help digitize its clinical trial processes. In a statement, TriNetX announced that it will be assisting the pharmaceutical company by using patient EHRs to optimize recruitment, streamline trial investigators’ workflows, and otherwise impact the design of investigational drug trials. Sanofi has made similar arrangements to bolster its clinical trials with Science 37 and Evidation in March and July of last year, respectively.
No comment yet.

GSK, Pfizer Lead in New Global Twitter Pharma Influencer Ranking - Teva is Dead, Last  #hcsmeufr #esante #digitalhealth


Tweeting to the top, GlaxoSmithKline and Pfizer tied for the No. 1 spot in the inaugural ranking of global pharma influencers by Owen Health. The U.K.-based healthcare marketing agency evaluated 22 pharma companies on authority, reach, activity, engagement and influence to rate the most and least adept when it comes to Twitter.

GSK and Pfizer both scored 75 and led the pack in influence, measured by Klout scores. Pfizer scored particularly well in reach—coming in second to Novartis—and also in being active, where it was just slightly behind Roche and Johnson & Johnson, which were Nos. 1 and 2 respectively in that measurement, Dean Mattingley, director at Owen Health, said in an email interview.

Meanwhile, GSK’s strength was engagement, which used a weighted measurement of likes, retweets and replies and took into account the number of followers and the volume of tweets sent during the month-long survey period. Mattingley said that that way, the engagement measure resulted in a score that "provides a clearer understanding of whose content is working the best.”

Owen Health used a snapshot approach for the study, analyzing more than 5,000 data points for the pharma Twitter accounts during the month of October 2017.

At the bottom of the ranking was Teva, with a score of 22.


Pharma Guy's curator insight, January 22, 12:31 PM

It’s obvious that pharma’s use of Twitter, for the most part, is being led by public relations people. There are “corporate” announcements meant for investors or the press while patients are largely being ignored.   Why is this happening? Largely because of two reasons; first, they are afraid of using social media for patient engagement and second because they don’t have the people to use social media as tool to reach customers.

Mapping des réalisations digitales proposées par l’industrie pharmaceutique  en France- MAJ janvier  #hcsmeufr #esante 


Reprenons les bonnes habitudes en ce début d’année. Aussi, je vous propose de continuer à consulter mon Mapping des réalisations digitales proposées par l'industrie pharmaceutique  en France, avec cette dernière MAJ. J’ai profité de la pause hivernale pour retirer les liens n’étant plus actifs. Durant cette année 2018, vous profiterez d’une mise à jour régulière…
Fabrice Vezin's curator insight, January 22, 4:45 AM
230 références citées et liens actifs vers les sites et applis

2017 FDA drug approvals  #hcsmeufr #esante #digitalhealth


The first-in-class monoclonal antibody (mAb) acts on both IL-4 and IL-13 signalling, modulating T helper 2-type responses, which are a unifying [...] anti-CD20 mAb rituximab held promise for the treatment of multiple sclerosis, but Roche did not

Krishan Maggon 's curator insight, January 19, 11:37 AM
46 NCE/NME new drugs approved in 2017

'Chemical MP3 Player' Can 3D Print Pharmaceuticals On-Demand from Digital Code  #hcsmeufr #3D4health #esante #digitalhealth


Have you ever taken your old compact discs and converted them to MP3 files so you could listen to your favorite music on your laptop, or through a portable MP3 device that’s much smaller than an unwieldy portable CD player? Now, researchers from the University of Glasgow are working on a very similar process, but instead of music files, they are using a chemical-to-digital converter to digitize the process of drug manufacturing; a chemical MP3 player, if you will, that can 3D print pharmaceuticals on demand.


3D printing in the pharmaceutical field is a fascinating concept, though not a new one. But this ‘Spotify for chemistry’ concept is new: it’s the first time we’ve seen an approach to manufacturing pharmaceuticals using digital code. According to Science, the University of Glasgow team “tailored a 3D printer to synthesize pharmaceuticals and other chemicals from simple, widely available starting compounds fed into a series of water bottle–size reactors.”

No comment yet.

3D printing drugs: more precise, more personalised - PharmaTimes Magazine January 2018 #hcsmeufr #esante #digitalhealth #3D4health


Printing out your own medicines is a long way off, but the possibilities are truly excitingImagine a future where patients with multiple chronic conditions no longer have to take numerous drugs several times a day – instead they can take one tablet containing all the required medications, once-daily, thanks to 3D printing.
No comment yet.